4-Bromo-N-(3,4-difluorophenyl)-2-fluorobenzenesulfonamide, 97%, 1g

3-Methyl-3H-[1,2,3]triazolo[4,5-b]pyridine-6-carboxylic acid, 98%, 100mg

Acide maléique, min 99 %, 100 g, emballage plastique.

2-CHloro-5-iodo-4-methyl-benzoic acid methyl ester, 95%, 5g

3-Amino-1-phenylcyclobutanecarbonitrile, 98%, 250mg

3-Acetyl-1-(p-tolylsulfonyl)pyrrole, 95.0%, 25g

N,N-Diallyl-4-methylbenzenesulfonamide, 95.0%, 1g

Methyl 5-cyano-1H-pyrrole-2-carboxylate, 95.0%, 1g

3,3-Dimethyl-7-nitro-2,3-dihydrobenzo[b][1,4]oxazepin-4(5h)-one, 95%, 500mg

1-(4-Bromophenyl)piperidine, 95.0%, 1g

1-Boc-4-aminopiperidine hydrochloride, 95.0%, 10g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalic acid, 95.0%, 1g

2-(4-Aminopiperidin-1-yl)acetamide, 97%, 250mg